Methods for the treatment of lysosomal storage diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12042476
APP PUB NO 20230277485A1
SERIAL NO

18106290

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This application relates to the use of 4-phenylbutyric acid, as well as pharmaceutically acceptable salts, co-crystals, polymorphs, solvates, analogs and/or pro-drugs thereof for the treatment of lysosomal storage disease, in particular gangliosidoses such as Tay Sachs disease (TSD) and Sandhoff disease (SD), alone, or in combination with other compounds and/or treatments.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MCMASTER UNIVERSITYONTARIO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Austin, Richard Ancaster, CA 8 63
Igdoura, Suleiman Dundas, CA 2 6
Nurse, Colin Dundas, CA 1 0
Weaver, Fiona Hamilton, CA 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jan 23, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 23, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 23, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00